NASDAQ:VIR

Vir Biotechnology Stock Predictions

Healthcare > Biotechnology

Buy VIR

*Your capital is at risk

$8.77

+0.0300 (+0.343%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

VIR Prediction Chart

VIR Predictions History

Latest community submissions for VIR.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
Alex Pippen @AlexPippen.164908	Jun 22, 2020	$37.32 -4.04%	$38.89	X	95.96%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for VIR with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT VIR BIOTECHNOLOGY, INC.

Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza A virus; and VIR-1111 for the prevention of human immunodeficiency virus....

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
RUN $12.83	18.86%	May 06
GLBE $31.61	5.35%	May 05
SAP $172.39	10.69%	May 05
W WCLD $27.34	27.18%	Apr 29
ADBE $243.57	7.61%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by